Logo image of BDX

BECTON DICKINSON AND CO (BDX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BDX - US0758871091 - Common Stock

205.67 USD
+6.71 (+3.37%)
Last: 1/6/2026, 3:26:02 PM
Fundamental Rating

5

Taking everything into account, BDX scores 5 out of 10 in our fundamental rating. BDX was compared to 185 industry peers in the Health Care Equipment & Supplies industry. BDX has an excellent profitability rating, but there are some minor concerns on its financial health. BDX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year BDX was profitable.
In the past year BDX had a positive cash flow from operations.
In the past 5 years BDX has always been profitable.
Each year in the past 5 years BDX had a positive operating cash flow.
BDX Yearly Net Income VS EBIT VS OCF VS FCFBDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

BDX's Return On Assets of 3.03% is fine compared to the rest of the industry. BDX outperforms 77.30% of its industry peers.
The Return On Equity of BDX (6.61%) is better than 80.54% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.24%, BDX is in the better half of the industry, outperforming 79.46% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BDX is below the industry average of 8.84%.
The last Return On Invested Capital (6.24%) for BDX is above the 3 year average (5.64%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.03%
ROE 6.61%
ROIC 6.24%
ROA(3y)2.9%
ROA(5y)3.12%
ROE(3y)6.24%
ROE(5y)6.77%
ROIC(3y)5.64%
ROIC(5y)5.24%
BDX Yearly ROA, ROE, ROICBDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

BDX's Profit Margin of 7.68% is fine compared to the rest of the industry. BDX outperforms 79.46% of its industry peers.
BDX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 15.70%, BDX belongs to the top of the industry, outperforming 84.86% of the companies in the same industry.
BDX's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 45.79%, BDX is not doing good in the industry: 61.08% of the companies in the same industry are doing better.
BDX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.7%
PM (TTM) 7.68%
GM 45.79%
OM growth 3Y4.99%
OM growth 5Y10.71%
PM growth 3Y-4.96%
PM growth 5Y10%
GM growth 3Y0.22%
GM growth 5Y0.65%
BDX Yearly Profit, Operating, Gross MarginsBDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

4

2. Health

2.1 Basic Checks

BDX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BDX has been reduced compared to 1 year ago.
Compared to 5 years ago, BDX has less shares outstanding
Compared to 1 year ago, BDX has an improved debt to assets ratio.
BDX Yearly Shares OutstandingBDX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
BDX Yearly Total Debt VS Total AssetsBDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.2 Solvency

An Altman-Z score of 2.18 indicates that BDX is not a great score, but indicates only limited risk for bankruptcy at the moment.
BDX has a better Altman-Z score (2.18) than 61.08% of its industry peers.
BDX has a debt to FCF ratio of 7.18. This is a slightly negative value and a sign of low solvency as BDX would need 7.18 years to pay back of all of its debts.
BDX has a Debt to FCF ratio of 7.18. This is in the better half of the industry: BDX outperforms 75.14% of its industry peers.
BDX has a Debt/Equity ratio of 0.73. This is a neutral value indicating BDX is somewhat dependend on debt financing.
BDX has a worse Debt to Equity ratio (0.73) than 69.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 7.18
Altman-Z 2.18
ROIC/WACC0.68
WACC9.21%
BDX Yearly LT Debt VS Equity VS FCFBDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 1.11 indicates that BDX should not have too much problems paying its short term obligations.
BDX's Current ratio of 1.11 is on the low side compared to the rest of the industry. BDX is outperformed by 85.41% of its industry peers.
BDX has a Quick Ratio of 1.11. This is a bad value and indicates that BDX is not financially healthy enough and could expect problems in meeting its short term obligations.
BDX has a worse Quick ratio (0.64) than 88.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.64
BDX Yearly Current Assets VS Current LiabilitesBDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.57% over the past year.
Measured over the past 5 years, BDX shows a small growth in Earnings Per Share. The EPS has been growing by 7.19% on average per year.
The Revenue has grown by 8.24% in the past year. This is quite good.
The Revenue has been growing slightly by 6.32% on average over the past years.
EPS 1Y (TTM)9.57%
EPS 3Y5.64%
EPS 5Y7.19%
EPS Q2Q%3.94%
Revenue 1Y (TTM)8.24%
Revenue growth 3Y4.99%
Revenue growth 5Y6.32%
Sales Q2Q%8.33%

3.2 Future

Based on estimates for the next years, BDX will show a small growth in Earnings Per Share. The EPS will grow by 7.68% on average per year.
BDX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.70% yearly.
EPS Next Y4.14%
EPS Next 2Y5.2%
EPS Next 3Y5.3%
EPS Next 5Y7.68%
Revenue Next Year2.92%
Revenue Next 2Y3.14%
Revenue Next 3Y3.18%
Revenue Next 5Y3.7%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BDX Yearly Revenue VS EstimatesBDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BDX Yearly EPS VS EstimatesBDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.26, which indicates a correct valuation of BDX.
Compared to the rest of the industry, the Price/Earnings ratio of BDX indicates a rather cheap valuation: BDX is cheaper than 89.73% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.87. BDX is valued slightly cheaper when compared to this.
BDX is valuated correctly with a Price/Forward Earnings ratio of 13.70.
Based on the Price/Forward Earnings ratio, BDX is valued cheaply inside the industry as 90.81% of the companies are valued more expensively.
BDX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.46.
Industry RankSector Rank
PE 14.26
Fwd PE 13.7
BDX Price Earnings VS Forward Price EarningsBDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

BDX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BDX is cheaper than 85.95% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BDX is valued cheaply inside the industry as 87.03% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 21.99
EV/EBITDA 12.64
BDX Per share dataBDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BDX does not grow enough to justify the current Price/Earnings ratio.
BDX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.44
PEG (5Y)1.98
EPS Next 2Y5.2%
EPS Next 3Y5.3%

6

5. Dividend

5.1 Amount

BDX has a Yearly Dividend Yield of 2.16%. Purely for dividend investing, there may be better candidates out there.
BDX's Dividend Yield is rather good when compared to the industry average which is at 0.20. BDX pays more dividend than 96.76% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, BDX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.16%

5.2 History

The dividend of BDX has a limited annual growth rate of 3.22%.
BDX has paid a dividend for at least 10 years, which is a reliable track record.
BDX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.22%
Div Incr Years34
Div Non Decr Years34
BDX Yearly Dividends per shareBDX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

BDX pays out 71.28% of its income as dividend. This is not a sustainable payout ratio.
The dividend of BDX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP71.28%
EPS Next 2Y5.2%
EPS Next 3Y5.3%
BDX Yearly Income VS Free CF VS DividendBDX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
BDX Dividend Payout.BDX Dividend Payout, showing the Payout Ratio.BDX Dividend Payout.PayoutRetained Earnings

BECTON DICKINSON AND CO

NYSE:BDX (1/6/2026, 3:26:02 PM)

205.67

+6.71 (+3.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)01-29 2026-01-29
Inst Owners94.4%
Inst Owner Change0%
Ins Owners0.36%
Ins Owner Change4.27%
Market Cap58.70B
Revenue(TTM)21.84B
Net Income(TTM)1.68B
Analysts72.22
Price Target209.03 (1.63%)
Short Float %1.7%
Short Ratio2.04
Dividend
Industry RankSector Rank
Dividend Yield 2.16%
Yearly Dividend4.16
Dividend Growth(5Y)3.22%
DP71.28%
Div Incr Years34
Div Non Decr Years34
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.54%
Min EPS beat(2)-0.05%
Max EPS beat(2)7.13%
EPS beat(4)3
Avg EPS beat(4)5.56%
Min EPS beat(4)-0.05%
Max EPS beat(4)14.05%
EPS beat(8)7
Avg EPS beat(8)5.42%
EPS beat(12)10
Avg EPS beat(12)4.67%
EPS beat(16)13
Avg EPS beat(16)5.77%
Revenue beat(2)0
Avg Revenue beat(2)-0.9%
Min Revenue beat(2)-1.22%
Max Revenue beat(2)-0.58%
Revenue beat(4)1
Avg Revenue beat(4)-0.99%
Min Revenue beat(4)-2.51%
Max Revenue beat(4)0.37%
Revenue beat(8)2
Avg Revenue beat(8)-0.95%
Revenue beat(12)5
Avg Revenue beat(12)-0.43%
Revenue beat(16)6
Avg Revenue beat(16)-0.46%
PT rev (1m)-0.25%
PT rev (3m)-5.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.34%
EPS NY rev (1m)0.09%
EPS NY rev (3m)0.06%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-4.53%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-1.59%
Valuation
Industry RankSector Rank
PE 14.26
Fwd PE 13.7
P/S 2.69
P/FCF 21.99
P/OCF 17.11
P/B 2.31
P/tB N/A
EV/EBITDA 12.64
EPS(TTM)14.42
EY7.01%
EPS(NY)15.02
Fwd EY7.3%
FCF(TTM)9.35
FCFY4.55%
OCF(TTM)12.02
OCFY5.84%
SpS76.52
BVpS88.96
TBVpS-37.23
PEG (NY)3.44
PEG (5Y)1.98
Graham Number169.89
Profitability
Industry RankSector Rank
ROA 3.03%
ROE 6.61%
ROCE 7.29%
ROIC 6.24%
ROICexc 6.33%
ROICexgc 26.66%
OM 15.7%
PM (TTM) 7.68%
GM 45.79%
FCFM 12.23%
ROA(3y)2.9%
ROA(5y)3.12%
ROE(3y)6.24%
ROE(5y)6.77%
ROIC(3y)5.64%
ROIC(5y)5.24%
ROICexc(3y)5.8%
ROICexc(5y)5.4%
ROICexgc(3y)27.15%
ROICexgc(5y)27.08%
ROCE(3y)6.53%
ROCE(5y)6.07%
ROICexgc growth 3Y-3.96%
ROICexgc growth 5Y9.78%
ROICexc growth 3Y7.94%
ROICexc growth 5Y16.75%
OM growth 3Y4.99%
OM growth 5Y10.71%
PM growth 3Y-4.96%
PM growth 5Y10%
GM growth 3Y0.22%
GM growth 5Y0.65%
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 7.18
Debt/EBITDA 3.14
Cap/Depr 30.87%
Cap/Sales 3.48%
Interest Coverage 5.46
Cash Conversion 58.23%
Profit Quality 159.12%
Current Ratio 1.11
Quick Ratio 0.64
Altman-Z 2.18
F-Score7
WACC9.21%
ROIC/WACC0.68
Cap/Depr(3y)33.59%
Cap/Depr(5y)39.6%
Cap/Sales(3y)3.86%
Cap/Sales(5y)4.6%
Profit Quality(3y)162.63%
Profit Quality(5y)151.73%
High Growth Momentum
Growth
EPS 1Y (TTM)9.57%
EPS 3Y5.64%
EPS 5Y7.19%
EPS Q2Q%3.94%
EPS Next Y4.14%
EPS Next 2Y5.2%
EPS Next 3Y5.3%
EPS Next 5Y7.68%
Revenue 1Y (TTM)8.24%
Revenue growth 3Y4.99%
Revenue growth 5Y6.32%
Sales Q2Q%8.33%
Revenue Next Year2.92%
Revenue Next 2Y3.14%
Revenue Next 3Y3.18%
Revenue Next 5Y3.7%
EBIT growth 1Y18.62%
EBIT growth 3Y10.23%
EBIT growth 5Y17.71%
EBIT Next Year20.6%
EBIT Next 3Y11.99%
EBIT Next 5Y12.28%
FCF growth 1Y-13.11%
FCF growth 3Y17.14%
FCF growth 5Y-0.73%
OCF growth 1Y-9.69%
OCF growth 3Y9.2%
OCF growth 5Y-0.62%

BECTON DICKINSON AND CO / BDX FAQ

Can you provide the ChartMill fundamental rating for BECTON DICKINSON AND CO?

ChartMill assigns a fundamental rating of 5 / 10 to BDX.


What is the valuation status for BDX stock?

ChartMill assigns a valuation rating of 6 / 10 to BECTON DICKINSON AND CO (BDX). This can be considered as Fairly Valued.


How profitable is BECTON DICKINSON AND CO (BDX) stock?

BECTON DICKINSON AND CO (BDX) has a profitability rating of 7 / 10.


What is the valuation of BECTON DICKINSON AND CO based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BECTON DICKINSON AND CO (BDX) is 14.26 and the Price/Book (PB) ratio is 2.31.


What is the financial health of BECTON DICKINSON AND CO (BDX) stock?

The financial health rating of BECTON DICKINSON AND CO (BDX) is 4 / 10.